Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma- R01 Aim 1a Renewal (SOS5C Trial)

NCT07206589 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07206589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma- R01 Aim 1a Renewal (SOS5C Trial)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
July 31, 2030
Enrollment
1,010 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, esophageal adenocarcinoma